Ingenza appoints Dr Mark Chadwick as strategic business advisor

Ingenza has announced the appointment of Dr Mark Chadwick to its team as strategic business advisor. Mark brings extensive industry experience to his new role, following his 30 years’ worth of roles in the pharma sphere.
Dr Chadwick has previously worked at small growth companies, covering areas including biotechnology, drug discovery and drug development. He holds a PhD in molecular biology from the University of Newcastle as well as an MBA from Imperial College London.
Dr Chadwick has gained valuable experience in both discovery and development businesses through his roles at BioFocus (now part of Charles River Laboratories), pharmaceutical services company Excelsyn and his role leading the commercial team at Arcinova.
Commenting on his new role, Dr Chadwick stated: “Ingenza has an illustrious track record of engineering diverse biological systems that help companies of all sizes to address challenges in human health and environmental sustainability. It is also committed to developing green biomanufacturing processes and together, these factors attracted me to work with the team. I’m very much looking forward to helping Ingenza to drive their growth strategy.”
Jaymin Amin, chief business officer at Ingenza, added: “Mark’s broad skill set will be a resource for us as we seek to turbocharge our new business development strategy and extendourcollaboratornetwork in the pharmaceutical field across discovery, development and manufacturing areas. We’re confident Mark will play an essential role in helping Ingenza to continue building its international reputation as a leading engineering biology company through his in-depth industry insights.”